Clinical Trials on N-RAS Gene Amplification
Total 99 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
Assiut UniversityNot yet recruitingGene Amplification
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; Applied Health Research Centre; Nuvation Bio Inc.; Takeda... and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationUnited States, Australia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid Tumors Harboring RAS Mutations or AmplificationsChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid Tumors Harboring RAS Mutations or AmplificationsChina
-
Jin-Hee AhnAsan Medical CenterUnknownHER-2 Gene Amplification | HER-2 Protein Overexpression
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
Tianjin Medical UniversityTianjin Medical University General HospitalRecruitingPD-L1 Gene Mutation | Positron Emission Tomography | PD-L1 Gene Amplification | PD-L1-related DiseaseChina
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
Arog Pharmaceuticals, Inc.AvailableFLT3-ITD Mutation | FLT3/TKD Mutation | PDGFR-Alpha D842V | PDGFRA Gene AmplificationItaly
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR1 Gene Mutation | FGFR3 Gene AmplificationUnited States, Canada
-
Tianjin Medical University Second HospitalRecruitingSolid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene TranslocationChina
-
Cogent Biosciences, Inc.Active, not recruitingAdvanced Solid Tumors | Cholangiocarcinoma | FGFR2 Gene Amplification | FGFR2 Gene Fusion/Rearrangement | Other Solid Tumors, Adult | FGFR3 Gene Amplification | Intrahepatic Cholangiocarcinoma (Icc) | FGFR2 Gene Short Variants | FGFR3 Gene Fusion/Rearrangement | FGFR3 Gene Short Variants | FGFR2 Genetic Alterations and other conditionsUnited States, Canada
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Orum Therapeutics USA, Inc.TerminatedHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Elevar TherapeuticsCompletedCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, United Kingdom, Spain, Italy, Taiwan, Sweden, Netherlands, Germany, Singapore, Australia, Hong Kong, South Korea
-
Inonu UniversityAnadolu UniversityActive, not recruitingInfections | Immune Response | Liver Transplant; Complications | Gene AmplificationTurkey
-
Sameek RoychowdhuryNational Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ALK Gene Mutation | Metastatic Malignant Neoplasm in the Brain | Advanced Malignant Neoplasm | ALK Fusion Protein Expression | Metastatic Malignant Neoplasm in the Central Nervous System | ROS1 Gene Mutation | ALK Gene... and other conditionsUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 and other conditionsUnited States
-
Tyra Biosciences, IncRecruitingAdvanced Solid Tumors | Solid Tumors | Solid Tumor, Adult | FGFR Gene Amplification | FGFR3 Gene Mutation | Metastatic Hepatocellular Carcinoma | FGFR3 Gene Alteration | FGFR Gene Alterations | FGFR4 Gene Mutation | FGFR4 Gene Fusions | FGF19 Gene Amplification | FGF19 Gene Overexpression | FGFR3 Gene Fusions | Locally...Taiwan, United States, Canada, South Korea
-
Biotie Therapies Inc.PRA Health Sciences; Tandem Labs; Xceleron IncCompletedN/A, as Healthy VolunteersNetherlands
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Blokhin's Russian Cancer Research CenterRecruitingColorectal Cancer Metastatic | Brain Metastases, Adult | HER2 Gene Mutation | MSI | BRAF Gene Mutation | Ras (KRAS or NRAS) Gene MutationRussian Federation
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
University Hospital, BrestUnknownBreast Neoplasms | HER-2 Gene AmplificationFrance
-
Karen-Lise Garm SpindlerCompletedColorectal Cancer Metastatic | KRAS Gene Mutation | Circulating Tumor DNA | BRAF Gene Mutation | NRAS Gene Mutation | Epidermal Growth Factor Receptor InhibitorDenmark
-
Merz Pharmaceuticals GmbHCompletedN/A, as no Specific Medical Condition Will be TreatedGermany
-
University of ChicagoNovartisTerminatedHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Human Papillomavirus Infection | Recurrent Oropharyngeal Squamous Cell Carcinoma | FGFR Gene Amplification | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | Recurrent Nasopharynx...United States
-
Centre Leon BerardRecruitingCancer | Cancer Metastatic | ALK Fusion Protein Expression | FGFR2 Gene Translocation | FGFR3 Gene Translocation | NTRK Family Gene Mutation | Gene Fusion | ROS1 Gene Translocation | NTRK Gene Fusion Overexpression | ATIC-ALK Fusion Protein Expression | BCR-FGFR1 Fusion Protein Expression | COL1A1-PDGFB Fusion... and other conditionsFrance, Denmark, Netherlands, Austria, Germany, Italy, United Kingdom, Czechia, Poland, Slovenia, Spain
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
OnKure, Inc.CompletedMelanoma | NRAS Gene Mutation | RAS MutationUnited States
-
N.N. Petrov National Medical Research Center of...RecruitingMelanoma | Lung Cancer | Pancreas Cancer | Refractory Cancer | Colorectal Cancer Recurrent | RAS Mutation | Ras (Kras or Nras) Gene MutationRussian Federation
-
University of VirginiaActive, not recruitingReal-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies (Lung001)Lung Cancer | ALK Gene Mutation | MET Gene Mutation | KRAS Mutation-Related Tumors | RET Gene Mutation | EGFR Gene Mutation | EGFR | ROS1 Gene Mutation | BRAFUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaCompletedGlioblastoma | Recurrent Glioblastoma | EGFR Gene Mutation | Supratentorial Glioblastoma | EGFR Gene Amplification | TP53 Wt AlleleUnited States
-
Tyra Biosciences, IncRecruitingFGFR Gene Amplification | FGFR3 Gene Mutation | FGFR3 Gene Alteration | FGFR Gene Alterations | FGFR3 Gene Fusions | Low-grade NMIBCUnited States, Spain, Italy, Australia
-
Hospital Erasto GaertnerAstraZenecaCompletedLung Neoplasms | KRAS Gene Mutation | EGFR Gene MutationBrazil
-
Sun Yat-sen University307 Hospital of PLA; Fudan University; West China Hospital; Tongji Hospital; Second... and other collaboratorsCompletedStomach Neoplasms | ERBB2 Gene Amplification | Neoplasms MetastasisChina
-
Merrimack PharmaceuticalsTerminatedStomach Cancer | Gastroesophageal Junction Cancer | HER-2 Gene Amplification | Esophagus CancerUnited States
-
Dr Cipto Mangunkusumo General HospitalCompletedColorectal Cancer | APC Gene Mutation | TP53 Gene Mutation | PIK3CA Gene Mutation | KRAS Mutation-Related Tumors | MLH1 Gene MutationIndonesia
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
Michael Wagner, MDEdgewood Oncology Inc.Active, not recruitingLiposarcoma | Myxoid Liposarcoma | MDM2 Gene Amplification | Metastatic Liposarcoma | CIC-Rearranged Sarcoma | Unresectable Liposarcoma | Recurrent LiposarcomaUnited States
-
Xiaohua ZhuRecruitingNSCLC Stage IV | PD-L1 Gene AmplificationChina
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
Cogent Biosciences, Inc.RecruitingNon-Small Cell Lung Cancer | ERBB2 Gene Amplification | HER2 | Advanced Solid Tumor, Adult | HER2 Overexpression | ERBB2 Altered Breast CancerUnited States
-
Day One Biopharmaceuticals, Inc.TerminatedMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification | BRAF Gene Fusion and other conditionsSpain, Belgium, United States, Canada, Australia, France, South Korea